SE9904581D0 - A novel helicobacter pylori-binding substance and use thereof - Google Patents

A novel helicobacter pylori-binding substance and use thereof

Info

Publication number
SE9904581D0
SE9904581D0 SE9904581A SE9904581A SE9904581D0 SE 9904581 D0 SE9904581 D0 SE 9904581D0 SE 9904581 A SE9904581 A SE 9904581A SE 9904581 A SE9904581 A SE 9904581A SE 9904581 D0 SE9904581 D0 SE 9904581D0
Authority
SE
Sweden
Prior art keywords
helicobacter pylori
binding substance
novel helicobacter
binding
identification
Prior art date
Application number
SE9904581A
Other languages
English (en)
Swedish (sv)
Inventor
Karl-Anders Karlsson
Irene Leonardsson
Susann Teneberg
Jonas Aangstroem
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Priority to SE9904581A priority Critical patent/SE9904581D0/xx
Publication of SE9904581D0 publication Critical patent/SE9904581D0/xx
Priority to RU2002118703/15A priority patent/RU2283115C2/ru
Priority to PL00356329A priority patent/PL356329A1/xx
Priority to EEP200200312A priority patent/EE200200312A/xx
Priority to AU24188/01A priority patent/AU783876B2/en
Priority to CA002392766A priority patent/CA2392766A1/en
Priority to US10/149,608 priority patent/US20040086514A1/en
Priority to IL15024700A priority patent/IL150247A0/xx
Priority to PCT/SE2000/002567 priority patent/WO2001043751A1/en
Priority to HU0204243A priority patent/HUP0204243A3/hu
Priority to SK815-2002A priority patent/SK8152002A3/sk
Priority to CNB008172927A priority patent/CN100389773C/zh
Priority to JP2001544888A priority patent/JP2003517015A/ja
Priority to CZ20021989A priority patent/CZ20021989A3/cs
Priority to NZ520111A priority patent/NZ520111A/en
Priority to EP00987920A priority patent/EP1237558A1/en
Priority to ZA200204251A priority patent/ZA200204251B/en
Priority to NO20022890A priority patent/NO20022890L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9904581A 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof SE9904581D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof
EP00987920A EP1237558A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
PCT/SE2000/002567 WO2001043751A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
SK815-2002A SK8152002A3 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
EEP200200312A EE200200312A (et) 1999-12-15 2000-12-15 Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamine
AU24188/01A AU783876B2 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
CA002392766A CA2392766A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
US10/149,608 US20040086514A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
IL15024700A IL150247A0 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
RU2002118703/15A RU2283115C2 (ru) 1999-12-15 2000-12-15 Новые вещества, связывающиеся с helicobacter pylori, и их применение
HU0204243A HUP0204243A3 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
PL00356329A PL356329A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
CNB008172927A CN100389773C (zh) 1999-12-15 2000-12-15 新的能结合幽门螺杆菌的物质及其用途
JP2001544888A JP2003517015A (ja) 1999-12-15 2000-12-15 ヘリコバクターピロリ結合性新規物質およびその用途
CZ20021989A CZ20021989A3 (cs) 1999-12-15 2000-12-15 Látka, která váľe Helicobacter pylori, farmaceutický prostředek je obsahující a její pouľití
NZ520111A NZ520111A (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
ZA200204251A ZA200204251B (en) 1999-12-15 2002-05-28 Novel helicobacter pylori-binding substances and use thereof.
NO20022890A NO20022890L (no) 1999-12-15 2002-06-17 Nye Heliobacter pylori-bindende substanser samt anvendelse derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof

Publications (1)

Publication Number Publication Date
SE9904581D0 true SE9904581D0 (sv) 1999-12-15

Family

ID=20418126

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof

Country Status (18)

Country Link
US (1) US20040086514A1 (cg-RX-API-DMAC7.html)
EP (1) EP1237558A1 (cg-RX-API-DMAC7.html)
JP (1) JP2003517015A (cg-RX-API-DMAC7.html)
CN (1) CN100389773C (cg-RX-API-DMAC7.html)
AU (1) AU783876B2 (cg-RX-API-DMAC7.html)
CA (1) CA2392766A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20021989A3 (cg-RX-API-DMAC7.html)
EE (1) EE200200312A (cg-RX-API-DMAC7.html)
HU (1) HUP0204243A3 (cg-RX-API-DMAC7.html)
IL (1) IL150247A0 (cg-RX-API-DMAC7.html)
NO (1) NO20022890L (cg-RX-API-DMAC7.html)
NZ (1) NZ520111A (cg-RX-API-DMAC7.html)
PL (1) PL356329A1 (cg-RX-API-DMAC7.html)
RU (1) RU2283115C2 (cg-RX-API-DMAC7.html)
SE (1) SE9904581D0 (cg-RX-API-DMAC7.html)
SK (1) SK8152002A3 (cg-RX-API-DMAC7.html)
WO (1) WO2001043751A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200204251B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20010118L (fi) * 2001-01-19 2002-07-20 Carbion Oy Uudet helicobacter pylori reseptorit ja niiden käyttö
EP1411952B1 (en) * 2001-06-29 2009-04-22 Glykos Finland Oy Use of at least one glycoinhibitor substance against infectious diseases
FI20011403L (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
AU2003201619A1 (en) * 2002-01-18 2003-07-30 Biotie Therapies Corporation Novel binding epitopes for helicobacter pylori and use thereof
EP1332759B1 (en) * 2002-02-04 2005-09-28 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter
EP2272522B1 (en) * 2002-06-28 2017-09-06 Nestec S.A. Therapeutic compositions for use in prophylaxis or treatment of diarrheas
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
EP1866071A4 (en) * 2005-03-03 2013-04-24 Univ Indiana Res & Tech Corp PERMETHYLATION OF OLIGOSACCHARIDES
JP4677525B2 (ja) * 2005-08-23 2011-04-27 国立大学法人 長崎大学 ヘリコバクター・ピロリの空胞化毒素の検出試薬および検出方法
FR2906808B1 (fr) * 2006-10-10 2012-10-05 Univ Nantes Utilisation d'anticorps monoclonaux specifiques de la forme o-acetylee du ganglioside gd2 dans le traitement de certains cancers
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
EP2098238B1 (en) * 2007-01-12 2012-10-17 The Noguchi Institute Helicobacter pylori growth inhibitor containing a monosaccharide derivative having an n-acetylglucosaminyl-group linked at the alpha position
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
GB0817908D0 (en) * 2008-10-01 2008-11-05 Univ Ghent Blood group a/b/h determinant on type 1 core glycosphinglipids chain as recognition point for the fedf protein of f18-fimbriated enterotoxigenic
JP5383692B2 (ja) 2008-10-10 2014-01-08 公益財団法人野口研究所 ピロリ菌増殖抑制剤
EP2844301A2 (en) * 2012-05-04 2015-03-11 Ineb-instituto de Engenharia Biomédica Microspheres for treating helicobacter pylori infections

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
US4678747A (en) * 1983-02-18 1987-07-07 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies for detection of an H (O) blood group antigen
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
US4971905A (en) * 1987-08-11 1990-11-20 Pacific Northwest Research Foundation Diagnosis of cancerous or precancerous conditions in human secretory epithelia by enzyme activity of β-1-3N-acetylglucosaminyltransferase
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
US6406894B1 (en) * 1992-12-11 2002-06-18 Glycorex Ab Process for preparing polyvalent and physiologically degradable carbohydrate-containing polymers by enzymatic glycosylation reactions and the use thereof for preparing carbohydrate building blocks
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
US6300113B1 (en) * 1995-11-21 2001-10-09 New England Biolabs Inc. Isolation and composition of novel glycosidases
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
WO1995029927A2 (en) * 1994-05-02 1995-11-09 Biomira, Inc. Process for preparation of glycosides of tumor-associated carbohydrate antigens
PL325873A1 (en) * 1995-09-29 1998-08-17 Glycim Oy Synthetic multivalent polysaccharide slex containing polylactose amines and methods of obtaining same
DE69737496D1 (de) * 1996-01-30 2007-05-03 Glycomimetics Inc SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE
US6841543B1 (en) * 1996-01-31 2005-01-11 President And Fellows Of Harvard College Methods of inhibiting production of T helper type 2 cytokines in human immune cells
US6709656B1 (en) * 1996-06-10 2004-03-23 Thomas Boren Helicobacter pylori adhesin binding group antigen
EP0926154B1 (en) * 1996-07-23 2010-01-27 Seikagaku Corporation Novel lactosamine oligosaccharides and process for the preparation thereof
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
US6902903B1 (en) * 1996-12-19 2005-06-07 Chiron Corporation Helicobacter pylori diagnostics
CN1281355A (zh) * 1997-12-12 2001-01-24 三阳株式会社 用于基因递送的生物可降解性混合聚合胶束
US6410057B1 (en) * 1997-12-12 2002-06-25 Samyang Corporation Biodegradable mixed polymeric micelles for drug delivery
JP4318765B2 (ja) * 1998-04-01 2009-08-26 雪印乳業株式会社 ピロリ菌感染防御剤
KR100460173B1 (ko) * 1998-12-11 2004-12-04 겐 코오포레이션 헬리코박터 파일로리 정착 억제제
US20010051349A1 (en) * 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20030100508A1 (en) * 1999-02-24 2003-05-29 Maryline Simon Carbohydrate epitope mimic compounds and uses thereof
WO2000070060A1 (en) * 1999-05-18 2000-11-23 University Of Iowa Research Foundation Production of complex carbohydrates
AUPQ275799A0 (en) * 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
FI19992070A7 (fi) * 1999-09-28 2001-03-29 Carbion Oy Uudet fukosyloidut oligosakkaridit ja menetelmä niiden valmistamiseksi
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20010118L (fi) * 2001-01-19 2002-07-20 Carbion Oy Uudet helicobacter pylori reseptorit ja niiden käyttö
EP1417965A1 (en) * 2002-11-07 2004-05-12 Vereniging Voor Christelijk Wetenschappelijk Onderwijs C-type lectin binding molecules, identification and uses thereof
ES2344114T3 (es) * 2004-05-11 2010-08-18 De Staat Der Nederlanden, Vert. Door De Minister Van Vws Lipooligosacaridos de neisseria meningitidis igtb como adyuvante.
EP1787128A2 (en) * 2004-07-09 2007-05-23 Amaox, Inc. Immune cell biosensors and methods of using same
US8273357B2 (en) * 2004-07-16 2012-09-25 Massachusetts Institute Of Technology Antigen-carbohydrate conjugates

Also Published As

Publication number Publication date
HUP0204243A3 (en) 2003-08-28
US20040086514A1 (en) 2004-05-06
ZA200204251B (en) 2003-05-28
NO20022890L (no) 2002-08-15
CN1411376A (zh) 2003-04-16
AU2418801A (en) 2001-06-25
SK8152002A3 (en) 2002-11-06
NO20022890D0 (no) 2002-06-17
NZ520111A (en) 2004-08-27
CN100389773C (zh) 2008-05-28
CZ20021989A3 (cs) 2002-10-16
WO2001043751A1 (en) 2001-06-21
EP1237558A1 (en) 2002-09-11
RU2283115C2 (ru) 2006-09-10
CA2392766A1 (en) 2001-06-21
AU783876B2 (en) 2005-12-15
HUP0204243A2 (hu) 2003-03-28
EE200200312A (et) 2003-06-16
JP2003517015A (ja) 2003-05-20
RU2002118703A (ru) 2004-02-20
PL356329A1 (en) 2004-06-28
IL150247A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
BRPI0409969A (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
ATE271060T1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
EP1140840A4 (en) -G (V) -CARBOXYARYL SUBSTITUTED DIPHENYL UREASINE AS RAF KINASE INHIBITORS
HUP0203056A1 (hu) Vakcinakészítmény
ATE304358T1 (de) (s,s)-reboxetin zur behandlung von migränekopfschmerzen
ATE425248T1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
BR0001292A (pt) Desfolhante
DK1206484T3 (da) Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
NO20030802L (no) Aminoalkoksybenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme
NO20013787L (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
BRPI0411245A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
TW200504051A (en) Novel acridine derivatives and their use as medicaments
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
ATE369145T1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen
ATE206105T1 (de) Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen
CY1108781T1 (el) Εμβολιο ψαριων
CL2004001461A1 (es) Compuestos derivados de 1,2,3,4-tetrahidropirimidina, composicion farmaceutica y su procedimiento de preparacion, procedimiento de preparacion, utiles para tratar o prevenir la hepatitis c.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen